Versant Venture Capital III L.P. 13D and 13G filings for Flexion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-25 5:57 pm Sale | 2021-01-15 | 13D | Flexion Therapeutics, Inc. FLXN | Versant Venture Capital III L.P. | 1,388,683 2.800% | -2,550,409 (-64.75%) | Filing |